Somaxon Pharmaceuticals Inc (NASDAQ:SOMX.DL)
CAPS Rating:
A pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.
RSS Headlines
Fool UK
Recs
They need more cash in a future.